Strive- version 0.5.0.2 download
31 Oct 2019 0.0); erenumab 70 mg, - 0.3 (- 0.5, - 0.2) p = 0.130; erenumab 140 mg, - 0.6 (- 0.7, Download full-text PDF The EM study (NCT02456740, STRIVE) was an inter- sification of Headache Disorders 3rd Edition (ICHD-3).